According to Taro Pharmaceutical's latest financial reports the company's current revenue (TTM) is $0.61 B. In 2022 the company made a revenue of $0.56 B an increase over the years 2021 revenue that were of $0.56 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $0.61 B | 7.23% |
2022 | $0.56 B | 0.56% |
2021 | $0.56 B | -1.59% |
2020 | $0.57 B | -11.42% |
2019 | $0.64 B | -2.32% |
2018 | $0.66 B | -2.62% |
2017 | $0.68 B | -27.95% |
2016 | $0.94 B | 1.96% |
2015 | $0.92 B | 15.38% |
2014 | $0.80 B | 9.32% |
2013 | $0.73 B | 13.25% |
2012 | $0.65 B | 28.73% |
2011 | $0.50 B | 29.02% |
2010 | $0.39 B | 9.59% |
2009 | $0.35 B | |
2005 | $0.30 B | 6.32% |
2004 | $0.28 B | -9.93% |
2003 | $0.31 B | 49.1% |
2002 | $0.21 B | 40.93% |
2001 | $0.15 B |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $93.02 B | 15,128.84% | ๐บ๐ธ USA |
Novartis NVS | $51.01 B | 8,251.29% | ๐จ๐ญ Switzerland |
Pfizer PFE | $58.49 B | 9,476.67% | ๐บ๐ธ USA |
Merck MRK | $60.11 B | 9,741.40% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $37.84 B | 6,096.35% | ๐ฌ๐ง UK |
Teva Pharmaceutical Industries TEVA | $15.84 B | 2,494.18% | ๐ฎ๐ฑ Israel |